Current Opinion in Ophthalmology

Papers
(The median citation count of Current Opinion in Ophthalmology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Alternative therapies for dry eye disease48
History, presence, and future of mitomycin C in glaucoma filtration surgery39
Pseudoexfoliation syndrome and glaucoma: from genes to disease mechanisms38
Flanged fixation: Yamane technique and its application37
Complications of intravitreal injections: 202235
Safety profile of minimally invasive glaucoma surgery34
A review of late intraocular lens opacifications33
Early pars plana vitrectomy for proliferative diabetic retinopathy: update and review of current literature33
Retinal and choroidal manifestations of COVID-1930
Rho kinase (ROCK) inhibitors in the management of corneal endothelial disease29
Radiation therapy for uveal melanoma: a review of treatment methods available in 202128
Glaucoma and biomechanics26
Endophthalmitis after cataract surgery: an update on recent advances25
Automated deep learning in ophthalmology: AI that can build AI23
Dropless cataract surgery: modernizing perioperative medical therapy to improve outcomes and patient satisfaction22
What's trending: a review of social media in ophthalmology22
Vogt-Koyanagi-Harada disease21
Advances in corneal graft rejection18
Artificial intelligence in myopia: current and future trends18
Artificial intelligence in retinal imaging for cardiovascular disease prediction: current trends and future directions17
Glaucoma care during the coronavirus disease 2019 pandemic17
Drug-related adverse effects of antivascular endothelial growth factor agents17
Advancements in intraocular lens power calculation formulas17
Geographic atrophy: where we are now and where we are going16
Deep learning-based natural language processing in ophthalmology: applications, challenges and future directions16
Novel vitreous substitutes: the next frontier in vitreoretinal surgery16
The role of imaging technologies for ocular surface tumors16
Current status of home monitoring technology for age-related macular degeneration15
Generative adversarial networks in ophthalmology: what are these and how can they be used?15
Brolucizumab for the treatment of diabetic macular edema14
Advances in perimetry for glaucoma14
The role of environment in the pathogenesis of keratoconus14
Description and management of retinopathy of prematurity reactivation after intravitreal antivascular endothelial growth factor therapy14
Gaps in standards for integrating artificial intelligence technologies into ophthalmic practice14
Applications of interpretability in deep learning models for ophthalmology13
Downbeat nystagmus: a clinical review of diagnosis and management13
Artificial intelligence and ophthalmic surgery12
How glaucoma care changed for the better after the pandemic12
Pregnancy and the eye12
Metabolic syndrome and the aging retina12
Recent advances in the management of proliferative diabetic retinopathy12
Visual disturbances during prolonged space missions12
The management of neurotrophic keratitis12
Artificial intelligence and corneal diseases12
Pharmacological strategies for treating presbyopia12
The role of trabeculectomy in the era of minimally invasive glaucoma surgery12
Recent developments in the use of optical coherence tomography for glaucoma12
Corneal hysteresis: ready for prime time?11
Stem cell-derived retinal pigment epithelium transplantation in age-related macular degeneration: recent advances and challenges11
Update on ophthalmic manifestations of systemic lupus erythematosus: pathogenesis and precision medicine11
Artificial intelligence in ophthalmology: an insight into neurodegenerative disease11
Novel technical and privacy-preserving technology for artificial intelligence in ophthalmology11
Cataract surgery and intraocular lens placement in patients with Fuchs corneal dystrophy: a review of the current literature11
Emerging treatments for geographic atrophy in age-related macular degeneration11
Advances in drug therapy and delivery for cataract treatment10
Metaplasticity: a key to visual recovery from amblyopia in adulthood?10
Artificial intelligence and complex statistical modeling in glaucoma diagnosis and management10
The American Academy of Ophthalmology IRIS Registry (Intelligent Research In Sight): current and future state of big data analytics10
Artificial intelligence-based predictions in neovascular age-related macular degeneration10
Multimodal imaging in infectious and noninfectious intermediate, posterior and panuveitis10
Role of corneal biopsy in the management of infectious keratitis10
An update on immediate sequential bilateral cataract surgery10
Current treatment strategies for symptomatic vitreous opacities10
Complications of retinopathy of prematurity treatment10
Artificial intelligence in dementia9
Current and future therapies for persistent corneal epithelial defects and neurotrophic keratopathy9
Future of virtual education and telementoring9
Optic perineuritis9
Cell therapy in corneal endothelial disease9
Towards effective data sharing in ophthalmology: data standardization and data privacy9
Current status and practical considerations of artificial intelligence use in screening and diagnosing retinal diseases: Vision Academy retinal expert consensus9
Epithelial thickness mapping for corneal refractive surgery8
Is laser trabeculoplasty the new star in glaucoma treatment?8
Clinician-driven artificial intelligence in ophthalmology: resources enabling democratization8
Advances in medical therapy for glaucoma8
Phakic intraocular lenses: an update and review for the treatment of myopia and myopic astigmatism in the United States8
New strategies for the management of ocular surface disease in glaucoma patients8
Peripheral ulcerative keratitis due to systemic diseases8
Development of the Port Delivery System with ranibizumab for neovascular age-related macular degeneration8
Drug-induced maculopathy8
Gut microbiome and retinal diseases: an updated review8
Ocular leprosy: from bench to bedside8
Optimizing the ocular surface prior to cataract surgery8
Beyond traditional subjective refraction7
The impact of artificial intelligence on retinal disease management: Vision Academy retinal expert consensus7
Leber hereditary optic neuropathy: new and emerging therapies7
Proteomics in uveal melanoma7
Photobiomodulation therapy in age-related macular degeneration7
Private equity in ophthalmology: lessons from other specialties7
Driving forces and current trends in private equity acquisitions within ophthalmology7
Ocular leptospirosis: lack of awareness among ophthalmologists and challenges in diagnosis7
New glaucoma drainage implants available to glaucoma surgeons7
Stargardt disease masquerades7
The relationship between dietary patterns and ophthalmic disease7
Adult retinopathy of prematurity: treatment implications, long term sequelae, and management7
The evolving field of Big Data: understanding geographic information systems analysis and its transformative potential in ophthalmic research7
Artificial intelligence for home monitoring devices7
Minimally invasive glaucoma surgery in childhood glaucoma7
Opioids and ophthalmology: review of the current literature7
Telemedicine in neuro-ophthalmology7
Loose zonules in cataract surgery7
Translational and clinical advancements in management of proliferative vitreoretinopathy6
The role of clinical examination of the optic nerve head in glaucoma today6
Assistive applications of artificial intelligence in ophthalmology6
Update on corneal collagen crosslinking for ectasia6
Descemet membrane endothelial keratoplasty in complex eyes6
Treatment of metastatic uveal melanoma in 2022: improved treatment regimens and improved prognosis6
An overview of peripapillary hyperreflective ovoid mass-like structures6
Systemic retinal biomarkers6
Perturbations of the ocular surface microbiome and their effect on host immune function6
Clinical guidelines for the management of keratoconus patients with gas permeable contact lenses based on expert consensus and available evidence6
Clinical outcomes of slow-coagulation continuous-wave transscleral cyclophotocoagulation laser for treatment of glaucoma6
Occlusive retinal vasculitis: novel insights into causes, pathogenesis and treatment6
Explainable artificial intelligence in ophthalmology6
Indications for surgical management of retained lens fragments6
Risk factors and management of choroidal effusions6
Ophthalmic manifestations of dementing disorders6
Incontinentia pigmenti and the eye6
Neurotrophic keratopathy and refractive surgery5
Cataract surgery in myopic eyes5
The case for standalone micro-invasive glaucoma surgery: rethinking the role of surgery in the glaucoma treatment paradigm5
Refractive lens exchange – who is getting it, what are they getting, how are they doing?5
Low-concentration povidone-iodine for the prevention of intraocular infections in ophthalmic surgery5
Refractive outcomes and complications following angle supported, iris fixated, and posterior chamber phakic intraocular lenses bilensectomy5
Rhino-orbital mucormycosis5
Future regenerative therapies for corneal disease5
Cataract surgery and the risk of progression of macular degeneration5
How private equity achieves return on investment in ophthalmology5
Oxidative stress and antioxidants in cataract development5
Editorial: Private equity investment and ophthalmology: why the discussion matters5
Ocular manifestations of rheumatoid arthritis5
Prevention of vision-threatening complications in diabetic retinopathy: two perspectives based on results from the DRCR Retina Network Protocol W and the Regeneron-sponsored PANORAMA5
Topography-guided excimer laser ablation4
Results from the Primary Tube Versus Trabeculectomy Study and translation to clinical practice4
Handling regular and irregular astigmatism during cataract surgery4
Building trust in real-world data: lessons from INSIGHT, the UK's health data research hub for eye health and oculomics4
Applications of artificial intelligence-enabled robots and chatbots in ophthalmology: recent advances and future trends4
Microinvasive glaucoma surgeries: critical summary of clinical trial data with and without phacoemulsification4
Endophthalmitis following cataract surgery: visual outcomes, microbial spectrum and complications4
Artificial intelligence for ocular oncology4
Chronic Relapsing Inflammatory Optic Neuropathy (CRION)4
Primary Retinal Detachment Outcomes Study: summary of reports number 1 to number 184
Juvenile open angle glaucoma: current diagnosis and management4
Expanding indications for corneal cross-linking3
Treatment of geographic atrophy: an update on data related to pegcetacoplan3
Identifying and addressing common contributors to nonadherence with ophthalmic medical therapy3
Future directions of glaucoma treatment: emerging gene, neuroprotection, nanomedicine, stem cell, and vascular therapies3
Intraoperative aberrometry: an update on applications and outcomes3
Neuro-ophthalmic complications of varicella-zoster virus3
Outcomes and predictive factors in multifocal and extended depth of focus intraocular lens implantation3
ChatGPT enters the room: what it means for patient counseling, physician education, academics, and disease management3
Light adjustable intraocular lenses: an updated platform for cataract surgery3
The evidence of implanting a different intraocular lens in each eye3
Challenges in management of the Boston Keratoprosthesis Type 13
Online intraocular lens calculation3
Light adjustable intraocular lenses in cataract surgery: considerations3
Private equity in ophthalmology: differences between present versus past3
Cataract surgery in adult eyes with short axial length3
Diversity, equity and inclusion in ophthalmology3
Cataract surgery after corneal refractive surgery: preoperative considerations and management3
To sell or not to sell: considerations when evaluating private equity acquisitions3
Gene therapy for age-related macular degeneration: potential, feasibility, and pitfalls3
Pilocarpine 1.25% and the changing landscape of presbyopia treatment3
Artificial intelligence enabled smart digital eye wearables3
Opsoclonus and ocular flutter: evaluation and management3
Changes to ophthalmic clinical care during the coronavirus disease 2019 pandemic3
Pediatric cataract surgery: considerations and updates in diagnosis and management2
Uveal melanoma: laboratory advances and new frontiers in patient care2
Cell therapy for retinal disease2
Artificial intelligence for glaucoma: state of the art and future perspectives2
A review of ophthalmic manifestations of inflammatory bowel disease and associated treatments2
Efferent neuro-ophthalmic complications of coronavirus disease 20192
Orbital inflammatory disorders: new knowledge, future challenges2
Updated safety precautions and guidance on eye banking procedures during the coronavirus disease 2019 pandemic2
Assessment of visual field progression in glaucoma2
Challenges and controversies in ophthalmology in 20232
Post-cataract surgery optic neuropathy: a chronological narrative review of the literature and speculation on pathogenesis2
Systemic considerations with pigmented fundus lesions and retinal pigment epithelium hamartomas in Turcot syndrome2
Toward safer ophthalmic artificial intelligence via distributed validation on real-world data2
Identifying geographic atrophy2
Stellate nonhereditary idiopathic foveomacular retinoschisis and an approach to the differential diagnosis of macular star2
Chopping techniques in cataract surgery2
Update on maculopathy secondary to pentosan polysulfate toxicity2
Recent evidence of economic evaluation of artificial intelligence in ophthalmology2
Efficacy of teprotumumab therapy in patients with long-duration thyroid eye disease2
Artificial intelligence in glaucoma: posterior segment optical coherence tomography2
Novel oral medications for retinal disease: an update on clinical development2
A review of posterior chamber phakic intraocular lenses2
Advances in eye banking and corneal tissue processing2
Vision rehabilitation in glaucoma patients2
Contractual considerations in the private equity era2
Follow-up studies of the classical landmark studies in Glaucoma2
Endothelial cell loss associated with minimally invasive glaucoma surgery2
Efficient use of ultrasound in cataract surgery2
Role of therapeutic contact lenses in management of corneal disease2
Cranial nerve involvement, visual complications and headache syndromes in Lyme disease2
The role of eye banking with cell-based therapies2
New views on three-dimensional imaging technologies for glaucoma: an overview2
Uveitis and glaucoma: a look at present day surgical options2
Clinical applications of bioengineered tissue-cellular products for management of corneal diseases2
Management of inflammation after the cataract surgery2
Effects of systemic targeted immunosuppressive therapy on ocular surface2
Immediately sequential bilateral cataract surgery2
Geographic atrophy: current and future therapeutic agents and practical considerations for retinal specialists2
Recent advances in diagnosis and management of sympathetic ophthalmia2
Therapy for contact lens-related ulcers2
Safety of recent ophthalmic drugs and devices for wet macular degeneration2
Private equity acquisitions: physician considerations at different stages of career2
Review and analysis of history and utilization of pneumatic retinopexy after pneumatic retinopexy versus vitrectomy for the management of primary rhegmatogenous retinal detachment outcomes randomized 2
Implications of the presence of private equity in ophthalmology: an academic perspective2
Enhanced durability and evolution of retreatment criteria of intravitreal antivascular endothelial growth factor agents for diabetic macular edema2
0.061779022216797